-+ 0.00%
-+ 0.00%
-+ 0.00%
Aardvark Therapeutics Appoints David Zhang as Independent Director
Share
Listen to the news
Aardvark Therapeutics Appoints David Zhang as Independent Director
  • Aardvark Therapeutics appointed David Zhang as an independent director in October 2026.
  • Zhang brings more than 25 years of experience, including oversight of CAMZYOS pivotal trial design at MyoKardia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130800PRIMZONEFULLFEED9877011) on November 13, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending